Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Sell

Exponential Moving Average

Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Sell

Wall Street Data Solutions Rating

Neutral

B

Mind Medicine (MindMed) Inc. Common Shares (MNMD)

Medicinal Chemicals & Botanical Products

https://www.mindmed.co

Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies.

ONE WORLD TRADE CENTER, SUITE 8500
NEW YORK, NY

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/03/2020

Market Cap

520,707,776

Shares Outstanding

40,100,000

Weighted SO

40,094,708

Total Employees

N/A

Upcoming Earnings

08/01/2024

Similar Tickers

CYBN --.--%

SEEL --.--%

GHRS --.--%

AWKNF --.--%

ATAI --.--%

FRLN --.--%

BPTH --.--%

VCNX --.--%

ELYM --.--%

Beta

2.3810

Last Div

0.0000

Range

2.41-12.22

Chg

-0.0200

Avg Vol

1358364

Mkt Cap

520707776

Exch

NASDAQ

Country

CA

Phone

650 208 2454

DCF Diff

4.2346

DCF

2.1854

Div Yield

0.0000

P/S

107.6287

EV Multiple

-3.3850

P/FV

2.2779

Div Yield %

0.0000

P/E

-4.5103

PEG

0.0758

Payout

0.0000

Current Ratio

5.9190

Quick Ratio

5.9190

Cash Ratio

5.8100

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

506.2069

CCC

-506.2069

Gross Margin

0.5624

Op Margin

-18.7026

Pretax Margin

-21.0916

Net Margin

-21.0916

Eff Tax Rate

0.0209

ROA

-0.3805

ROE

-0.7133

ROCE

-0.3998

NI/EBT

1.0000

EBT/EBIT

1.1277

EBIT/Rev

-18.7026

Debt Ratio

0.0904

D/E

0.1200

LT Debt/Cap

0.1072

Total Debt/Cap

0.1072

Int Coverage

68.7561

CF/Debt

-2.9999

Equity Multi

1.3271

Rec Turnover

0.0000

Pay Turnover

0.7210

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0180

OCF/Share

-1.0117

FCF/Share

-1.0117

Cash/Share

3.3810

OCF/Sales

-15.0373

FCF/OCF

1.0000

CF Coverage

-2.9999

ST Coverage

0.0000

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

2.2779

P/B

2.2779

P/S

107.6287

P/E

-4.5103

P/FCF

-7.1575

P/OCF

-6.3263

P/CF

-6.3263

PEG

0.0758

P/S

107.6287

EV Multiple

-3.3850

P/FV

2.2779

DPS

0.0000

Latest Headlines (EST)

MarketWatch Jan 03, 11:17 One backer of MDMA therapy sees 'exponential' growth upon FDA approval this year MarketWatch Dec 14, 12:39 MindMed’s stock boosted by positive data in trial of LSD as treatment for anxiety disorder

Revenue Product Segmentation